The Thyroid Epidemiology, Audit, and Research Study (TEARS): The Natural History of Endogenous Subclinical Hyperthyroidism
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: For patients with subclinical hyperthyroidism (SH), the objective of the study was to define the rates of progression to frank hyperthyroidism and normal thyroid function. DESIGN: Record-linkage technology was used retrospectively to identify patients with SH in the general population of Tayside, Scotland, from January 1, 1993, to December 31, 2009. PATIENTS: All Tayside residents with at least two measurements of TSH below the reference range for at least 4 months from baseline and normal free T(4)/total T(4) and total T(3) concentrations at baseline were included as potential cases. Using a unique patient identifier, data linkage enabled a cohort of SH cases to be identified from prescription, admission, and radioactive iodine treatment records. Cases younger than 18 yr of age were also excluded from the study. OUTCOME MEASURES: The status of patients was investigated at 2, 5, and 7 yr after diagnosis. RESULTS: We identified 2024 cases with SH, a prevalence of 0.63% and an incidence of 29 per 100,000 in 2008. Most SH cases without thyroid treatment remained as SH at 2 (81.8%), 5 (67.5%), and 7 yr (63.0%) after diagnosis. Few patients (0.5-0.7%) developed hyperthyroidism at 2, 5, and 7 yr. The percentage of SH cases reverting to normal increased with time: 17.2% (2 yr), 31.5% (5 yr), and 35.6% (7 yr), and this was more common in SH patients with baseline TSH between 0.1 and 0.4 mU/liter. CONCLUSION: Very few SH patients develop frank hyperthyroidism, whereas a much larger proportion revert to normal, and many remain with SH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although higher serum TSH values might occur naturally, as part of the ageing process, [15][16][17]”
From Hypothyroidism (2024) · cites this paper as [17]
In the citing paper
“This shift in the normal TSH distribution to a higher range in older individuals might represent a normal part of ageing,15-17,131”
From Hypothyroidism (2024) · cites this paper as [17]
In the citing paper
“studies in iodine-replete populations without thyroid disease have reported higher TSH concentrations in older individuals.15,17,19,20”
From Hypothyroidism (2024) · cites this paper as [17]
In the citing paper
“The progression of grade 1 SHyper to overt hyperthyroidism is uncommon, ranging from 0.5 to 0.7% over 7 years [32] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [32]
In the citing paper
“Pro-gression from SH to overt hyperthyroidism appears more likely if the TSH is suppressed (<0.01 mU/L), rather than low but detectable (0.01-0.4 mU/L) (375-377).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [375]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 1×
“7% had subclinical hyperthyroidism and the prevalence was greater in females and increased with age (16).”
BackgroundThe Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824 · cited 3×
“J Clin Endocrinol Metab, January 2011, 96(1):E1–E8 jcem.”
BackgroundInfluentialThe incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · cited 1×
“may be explained by this variability (22).”
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 1×
“Some studies have suggested that patients with subclinical hyperthyroidism may develop overt hyperthyroidism at a rate of 1–5% per year (5, 6).”
BackgroundFade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · cited 3×
“This finding is similar to other studies (7, 8), which suggested that the risk of developing hyperthyroid in those with low TSH was small.”
BackgroundResultTHE EPIDEMIOLOGY OF THYROID DISEASE AND IMPLICATIONS FOR SCREENING
Wang, C., & Crapo, L. M. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70240-1 · Cited by 525
Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK
Yu, N., Donnan, P. T., Murphy, M. J., & Leese, G. P. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03520.x · Cited by 213
Self-citationThe thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population
Flynn, R. W. V., MacDonald, T. M., Morris, A. D., Jung, R. T., & Leese, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032089 · Cited by 196
Self-citation
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
The epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Franklyn, J. A., & Boelaert, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60782-4 · Cited by 262
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2693 · Cited by 186
Self-citationSheehan, M. T. (2016) · Clinical Medicine & Research · doi:10.3121/cmr.2016.1309 · Cited by 179
Biondi, B., & Cooper, D. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709318 · Cited by 135
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
“…TSH in healthy older people being around 7·5 mIU/L.3 Although higher serum TSH values might occu r naturally, as part of the ageing process, 15 – 17 this effect could be highly pertinent to the mana gement of older individuals, particularly as symptoms such as tiredness and fatigue are common,…”
Thyroid function and the risk of dementia: The Rotterdam Study
Chaker, L., Wolters, F. J., Bos, D., Korevaar, T. I. M., Hofman, A., van der Lugt, A., Koudstaal, P. J., Franco, O. H., Dehghan, A., Vernooij, M. W., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003227 · Cited by 115
Chaker, L., Cooper, D. S., Walsh, J. P., & Peeters, R. P. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02016-0 · Cited by 174
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
Jonklaas, J., & Razvi, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30371-1 · Cited by 100
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98
The Thyroid in Mind: Cognitive Function and Low Thyrotropin in Older People
Gan, E. H., & Pearce, S. H. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2284 · Cited by 93
Thyroid dysfunction in the elderly
Boelaert, K. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.30 · Cited by 84
The Endocrinology of Ageing: A Mini-Review
Jones, C. M., & Boelaert, K. (2014) · Gerontology · doi:10.1159/000367692 · Cited by 94
Liothyronine use in a 17 year observational population‐based study ‐ the tears study
Leese, G. P., Soto‐Pedre, E., & Donnelly, L. A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13052 · Cited by 75
Self-citationEpidemiology of Thyroid Disorders
Vanderpump, M. P. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_6 · Cited by 100
Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism
Das, G., Ojewuyi, T. A., Baglioni, P., Geen, J., Premawardhana, L. D., & Okosieme, O. E. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04345.x · Cited by 61
Åsvold, B. O., Vatten, L. J., Midthjell, K., & Bjøro, T. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1724 · Cited by 56
Subclinical Thyroid Dysfunction and Frailty Among Older Men
Virgini, V. S., Rodondi, N., Cawthon, P. M., Harrison, S. L., Hoffman, A. R., Orwoll, E. S., Ensrud, K. E., Bauer, D. C., & for the Osteoporotic Fractures in Men (MrOS) Research Group (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3191 · Cited by 55
“Subclinical hyperthyroidism has been shown to be associated with osteoporosis (26–28), cognitive decline (11, 12), and atrial fibrillation (AF) (8).”
BackgroundGarg, A., & Vanderpump, M. P. J. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt024 · Cited by 61
Ruggeri, R. M., Trimarchi, F., & Biondi, B. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0321 · Cited by 53
Subclinical Hyperthyroidism and the Cardiovascular Disease
Delitala, A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-117893 · Cited by 58
“1) have a low risk to progression (less than 1 %) [30], while 20 % of patients with decreased TSH level (0.”
BackgroundCarlé, A., Andersen, S. L., Boelaert, K., & Laurberg, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0276 · Cited by 58
Franklyn, J. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12011 · Cited by 47
Amouzegar, A., Ghaemmaghami, Z., Beigy, M., Gharibzadeh, S., Mehran, L., Tohidi, M., & Azizi, F. (2017) · Thyroid · doi:10.1089/thy.2016.0409 · Cited by 52
“…over-activity in large populations is crucial; to our knowledge there is no prospective data documenting this in large cohorts; the majority of studies evaluating the spontaneous changes in subclinical hyper-thyroid patients report that progression to overt hyperthy-roidism is rare (5,22,23).”
InfluentialSubclinical Hyperthyroidism: A Review of the Clinical Literature
Tsai, K., & Leung, A. M. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.02.002 · Cited by 45
Thyroid Hormone and Cardiac Disease: From Basic Concepts to Clinical Application
Mourouzis, I., Forini, F., Pantos, C., & Iervasi, G. (2011) · Journal of Thyroid Research · doi:10.4061/2011/958626 · Cited by 44
“Observational, large-scale studies on relationships between cardiovascular morbidity and mortality in exogenous subclinical hyperthyroidism induced by long-term LT4 treatment have yielded, however, conflicting results [67] and only in patients with endogenous subclinical hyperthyroidism an increased risk of nonfatal m…”
ResultThyroid disease in the perimenopause and postmenopause period
Uygur, M. M., Yoldemir, T., & Yavuz, D. G. (2018) · Climacteric · doi:10.1080/13697137.2018.1514004 · Cited by 52
Update on subclinical thyroid dysfunction
Hashimoto, K. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0182 · Cited by 56
“In general, SCHyper occurs with higher prevalence among women, older individuals, and those living in iodine-deficient regions [10, 84, 86-88].”
BackgroundInfluentialTabatabaie, V., & Surks, M. I. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/01.med.0000433055.99570.52 · Cited by 43
Yang, R., Yao, L., Fang, Y., Sun, J., Guo, T., Yang, K., & Tian, L. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0828-5 · Cited by 40
“[10] reported a prevalence of subclinical hyperthyroidism in Tayside, Scotland of 0.”
RetractedExpert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021)
Liu, Y., Shan, Z., & Endocrine Metabolic Diseases Group of the Chinese Geriatrics Society (2021) · Aging Medicine · doi:10.1002/agm2.12165 · Cited by 39
Jasim, S., & Gharib, H. (2017) · Endocrine Practice · doi:10.4158/ep171796.ra · Cited by 38
Shi, X., Jin, X., Xu, P., & Shen, H. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6643 · Cited by 39
“This condition is termed subclinical hyperthyroidism, and the long-term consequences of this disease remain uncertain (Vadiveloo et al., 2011).”
BackgroundManagement of Subclinical Hyperthyroidism
Wartofsky, L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2409 · Cited by 31
Cognitive functions and thyroid hormones secretion disorders
Przybylak, M., Grabowski, J., & Bidzan, L. (2021) · Psychiatria Polska · doi:10.12740/pp/112470 · Cited by 38
“[8] the prevalence was estimated at only 0.”
Thyroid Function Reference Intervals by Age, Sex, and Race
Li, Q., Tang, Y., Yu, X., Qin, G., Tian, L., Cheng, L., Lü, Y., Zhao, Z., Liu, L., Zhang, K., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-01559 · Cited by 32
Thyroid Disorders in Older Adults
Visser, W. E., Visser, T. J., & Peeters, R. P. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.008 · Cited by 35
Should we treat mild subclinical/mild hyperthyroidism? Yes
Wiersinga, W. M. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.03.008 · Cited by 32
“4 mU/l are less likely to progress [68] andmore likely to normalize TSH [61].”
BackgroundShould we treat mild subclinical/mild hyperthyroidism? No
Vanderpump, M. P. J. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.03.009 · Cited by 28
The Natural History of Subclinical Hyperthyroidism in Graves’ Disease: The Rule of Thirds
Zhyzhneuskaya, S., Addison, C., Tsatlidis, V., Weaver, J. U., & Razvi, S. (2016) · Thyroid · doi:10.1089/thy.2015.0470 · Cited by 22
“The progression of SH to overt hyperthyroidism is estimated to be 1% per year, as most patients either remain in the SH state or normalize TSH levels (3).”
Decision Making in Subclinical Thyroid Disease
Evron, J. M., & Papaleontiou, M. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.05.014 · Cited by 27
Seigel, S. C., & Hodak, S. P. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.016 · Cited by 31
“About one-third of patients with SH become euthyroid.(134) Establishing the diagnosis of SH should include a thorough medical history, a repeat TSH test over a 3-month to 6-month period to establish that the abnormal thyroid”
BackgroundSubclinical Hypothyroidism and Cardiovascular Risk: Recommendations for Treatment
Weiss, I. A., Bloomgarden, N. A., & Frishman, W. H. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e318227df87 · Cited by 23
Rosário, P. W., Carvalho, M. U. W. B. D., & Calsolari, M. R. (2015) · Clinical Endocrinology · doi:10.1111/cen.12979 · Cited by 19
Epidemiology of Thyroid Disease
Vanderpump, M. P. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96019-7 · Cited by 18
Cardiovascular outcomes in subclinical thyroid disease: an update
Ettleson, M. D. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000818 · Cited by 20
Subclinical Hyperthyroidism and Cardiovascular Disease
Kim, H. J., & McLeod, D. S. A. (2024) · Thyroid · doi:10.1089/thy.2024.0291 · Cited by 18
“32 Similar fi ndings have been reported in the Scottish Tayside population-based registry, TEARS.”
InfluentialGraves’ disease, multinodular goiter and subclinical hyperthyroidism
Lassen, P. B., Kyrilli, A., Lytrivi, M., & Corvilain, B. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.09.004 · Cited by 23
Approach to the Patient With a Suppressed TSH
Praw, S. S., & Brent, G. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac635 · Cited by 15
Naraintran, S., Sandeep Kumar David, S., Raveendran, K., & K., E. P. B. (2018) · International Surgery Journal · doi:10.18203/2349-2902.isj20181056 · Cited by 11
“This result was similar to many international studies.(6,7)”
ResultA retrospective study of the natural history of endogenous subclinical hyperthyroidism.
Poola, R., Mathiason, M. A., & Caplan, R. H. (2011) · PubMed · Cited by 10
Goichot, B., & Luca, F. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.09.009 · Cited by 12
Bilgir, O., Bilgir, F., Topcuoglu, T., Çalan, M., & Çalan, Ö. G. (2013) · Endocrine · doi:10.1007/s12020-013-9993-z · Cited by 9
Zhang, J., Rayamajhi, S., Thapa, A., Meng, G., Zhang, Q. H., Liu, L., Wu, H., Gu, Y., Zhang, S., Zhang, T., et al. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.07.019 · Cited by 7
Shin, K., Kim, J., Park, J. M., Oh, T. J., Kong, S. H., Ahn, C. H., Moon, J. H., Kim, M. J., & Moon, J. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-48199-x · Cited by 10
“Moreover, higher free T4 and lower TSH levels in false positive cases compared with true negative cases support that the ML-assisted system may screen more severe cases of subclinical thyrotoxicosis, which is likely to cause comorbidities 12,16–21 and progress to overt thyrotoxicosis 13–15 .”
ResultSubclinical Hyperthyroidism and Cardiovascular Risk: Recommendations for Treatment
Palmeiro, C., Davila, M. I., Bhat, M., Frishman, W. H., & Weiss, I. A. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e318294f6f1 · Cited by 13
A model of functional thyroid disease status over the lifetime
Dzierlenga, M. W., Allen, B. C., Ward, P. L., M.A., H. J. C. I., & Longnecker, M. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219769 · Cited by 9
Biondi, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99453-4 · Cited by 7
A Stepwise Approach to the Evaluation and Treatment of Subclinicalhyperthyroidism
Mai, V. Q., & Burch, H. B. (2012) · Endocrine Practice · doi:10.4158/ep12124.ra · Cited by 9
The “slightly” abnormal thyroid test: What is the pediatrician to do?
Gyuricsko, E. (2020) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2020.100770 · Cited by 9
Prevalencia e incidencia de los principales trastornos endocrinos y metabólicos
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70217-7 · Cited by 22
Aw, T. C., & Yap, C. Y. (2011) · Proceedings of Singapore Healthcare · doi:10.1177/201010581102000212 · Cited by 6
Yang, J., Zheng, Y., Li, C., Liu, Y., Zhou, Q., Gao, J. L., Meng, X., Zhang, K., Wang, W., Shao, C., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab855 · Cited by 4
Enfermedad tiroidea subclínica: revisión y enfoque clínico
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70219-0 · Cited by 19
Subclinical hyperthyroidism: first do no harm
Mitchell, A. L., & Pearce, S. H. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13070 · Cited by 5
NHG-Standaard Schildklieraando eningen (tweede herziening)
van Lieshout, J., Felix-Schollaart, B., Bolsius, E., de Boer, A. C. F. P., Burgers, J. S., Bouma, M., & Sijbom, M. (2013) · Cited by 7
Endogenous subclinical hyperthyroidism: who, when and why to treat
Biondi, B. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.69 · Cited by 5
Toni, M., Pineda, J., Anda, E., & Galofré, J. C. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.003 · Cited by 4
Clinical Implications and Management of Sub Clinical Hyperthyroidism: A Review
De, P., Pang, T., & Das, G. C. (2012) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2012.23004 · Cited by 5
“dictive utility of TSH in subclinical hyperthyroidism and the natural history depicted is quite variable [31-33].”
BackgroundKline, G. A., & Sadrzadeh, H. S. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803412-5.00002-1 · Cited by 4
Classification of Thyroid Diseases
Corbetta, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_2 · Cited by 3
Nishijima, Y., Murakami, T., Higaki, N., Tani, J., & Noguchi, H. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0424 · Cited by 3
Wei, G., Shen, Y., Wang, X., Xiong, D., Zhang, L., Zhao, T., Li, X., Sun, M., Yu, S., Huang, X., et al. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.111723 · Cited by 2
Bergeron, Y., & Fyles, J. (2009) · Presses de l'Université du Québec eBooks · doi:10.1515/9782760523821-028 · Cited by 2
Graves’ Disease and Toxic Nodular Goiter (Plummer’s Disease)
Barczyński, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_3 · Cited by 3
Correlation between wayne′s score and laboratory evidence of thyrotoxicosis in Nigeria
Sabir, A. A., Abubakar, S., Fasanmade, O. A., Haruna, G., Iwuala, S. O., & Ohwovoriole, A. E. (2014) · Sub-Saharan African Journal of Medicine · doi:10.4103/2384-5147.138944 · Cited by 2
“This is similar to other studies that found thyrotoxicosis to be more common in young females.[1,4,5] The negative correlation between age and Wayne’s score suggests that old age is associated with clinically less severe thyrotoxicosis and the diagnosis of thyrotoxicosis may be more difficult in the elderly.”
ResultAssociation Between Thyroid-Stimulating Hormone Level and Bell's Palsy
Stahl, A., Biadsee, A., Hornik‐Lurie, T., & Nageris, B. I. (2023) · Otology & Neurotology · doi:10.1097/mao.0000000000003926 · Cited by 1
Cooper, A., & Abraham, P. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000928 · Cited by 1
Subclinical Thyroid Dysfunction in the Elderly
Ko, K. D. (2014) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2014.18.3.111 · Cited by 1
The clinical impact of thyroid epidemiology
Leese, G., & Flynn, R. W. V. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-6-s64 · Cited by 1
Self-citationGhofir, B. H. P. D. A. (2015) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · Cited by 1
Thyroid disease in peri‑ and postmenopause period (literature review)
Zaidieva, Y. Z., Glazkova, A. V., & Kruchinina, E. V. (2020) · Medical alphabet · doi:10.33667/2078-5631-2019-4-33(408)-48-53 · Cited by 1
Surgical Management of Hyperthyroidism
Orloff, L. A., & Shindo, M. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-66127-0.00008-9 · Cited by 3
An Overview of Endogenous Subclinical Hyperthyroidism and Cardiac Disease
Woeber, K. A. (2016) · Endocrine Practice · doi:10.4158/ep161437.co · Cited by 1
Treatment options of subclinical hyperthyroidism and cardiovascular risk
Kyrilli, A., Lytrivi, M., Lassen, P. B., & Corvilain, B. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.01.008 · Cited by 3
Adhesion molecules before and after propylthiouracil in patients with subclinical hyperthyroidism
Bilgir, F., Bilgir, O., Akan, Ö. Y., & Demir, İ. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.8.1057 · Cited by 1
Study of the relationship of thyroid status and frailty in older Egyptian men
Ibrahim, M. H. E. D., Alsebaie, M. M., Elbendary, H. I., & Yousief, E. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_96_19 · Cited by 1
Subclinical Hyperthyroidism: Case Report and Review of the Literature
Tsai, K., & Leung, A. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_7 · Cited by 1
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_9 · Cited by 1
The Relationship and Research Progress be-tween Subclinical Thyroid Dysfunction and Osteoporosis
杨, 贤. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361416 · Cited by 2
Schott, M. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.06.003 · Cited by 1
Schott, M. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00355-5
Johansson, P. (2013) · Lund University Publications (Lund University) · doi:10.13140/rg.2.1.3188.4887 · Cited by 1
Schilddrüse und weibliche Fertilität
Stulnig, T. M. (2017) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-017-0007-z
“Auch die endogen bedingte Suppression des TSH ist oft reversibel, sodass nach 5 Jahren schon 31–51 % der Patienten eine normale Funktion aufweisen [12, 13].”
Background
Metadata
- Authors
- Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P.
- Affiliations
- University of Dundee (GB)
- Corresponding author
- Vadiveloo, Thenmalar
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-01
- Volume
- 96
- Issue
- 1
- Pages
- E1-E8
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2023374432
- Cited by
- 118
- References
- 25
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 5 · 2014: 4 · 2013: 11 · 2012: 11
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- subclinical hyperthyroidism, natural history (disease), thyroid-stimulating hormone, incidence, prevalence, thyroid function
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Hyperthyroidism, Male, Middle Aged, Scotland, Severity of Illness Index, Thyroid Gland, Thyrotropin, Thyroxine, Triiodothyronine, Incidence, Prevalence, Databases, Factual, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.